Is Geron Stock a Good Investment?
Geron Investment Advice | GERN |
- Examine Geron's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Geron's leadership team and their track record. Good management can help Geron navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Geron's business and its evolving consumer preferences.
- Compare Geron's performance and market position to its competitors. Analyze how Geron is positioned in terms of product offerings, innovation, and market share.
- Check if Geron pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Geron's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Geron stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Geron is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Geron Stock
Researching Geron's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 78.0% of the company shares are owned by institutional investors. The book value of Geron was currently reported as 0.46. The company recorded a loss per share of 0.27. Geron had not issued any dividends in recent years. The entity had 1058:1000 split on the 22nd of July 2014.
To determine if Geron is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Geron's research are outlined below:
| Geron generated a negative expected return over the last 90 days | |
| Geron has high historical volatility and very poor performance | |
| Geron may become a speculative penny stock | |
| The company reported the previous year's revenue of 76.99 M. Net Loss for the year was (174.57 M) with loss before overhead, payroll, taxes, and interest of (28 M). | |
| Geron currently holds about 219.29 M in cash with (218.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58. | |
| Geron has a frail financial position based on the latest SEC disclosures | |
| Over 78.0% of the company shares are owned by institutional investors | |
| Latest headline from globenewswire.com: Geron Corporation Shareholder Notice Robbins LLP Reminds Investors of the Pending GERN Class Action Lawsuit |
Geron Quarterly Cash And Short Term Investments |
|
Geron uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Geron. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Geron's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Geron's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Geron's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-05-02 | 2024-03-31 | -0.1 | -0.09 | 0.01 | 10 | ||
2024-02-28 | 2023-12-31 | -0.1 | -0.09 | 0.01 | 10 | ||
2023-08-03 | 2023-06-30 | -0.08 | -0.09 | -0.01 | 12 | ||
2022-11-03 | 2022-09-30 | -0.09 | -0.1 | -0.01 | 11 | ||
2022-05-09 | 2022-03-31 | -0.1 | -0.09 | 0.01 | 10 | ||
2021-11-09 | 2021-09-30 | -0.09 | -0.08 | 0.01 | 11 | ||
2021-05-10 | 2021-03-31 | -0.08 | -0.09 | -0.01 | 12 | ||
2021-03-11 | 2020-12-31 | -0.06 | -0.07 | -0.01 | 16 |
Know Geron's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Geron is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Geron backward and forwards among themselves. Geron's institutional investor refers to the entity that pools money to purchase Geron's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-12-31 | 13.1 M | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 11.7 M | Woodline Partners Lp | 2024-12-31 | 11.6 M | Vestal Point Capital Lp | 2024-12-31 | 11 M | Darwin Global Management, Ltd. | 2024-12-31 | 9.6 M | Segall Bryant & Hamill | 2024-12-31 | 7.4 M | Eventide Asset Management, Llc | 2024-12-31 | 7.1 M | Millennium Management Llc | 2024-12-31 | 7 M | Braidwell Lp | 2024-12-31 | 7 M | Blackrock Inc | 2024-12-31 | 49.9 M | Vanguard Group Inc | 2024-12-31 | 33.5 M |
Geron's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.11 B.Market Cap |
|
Geron's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.29) | (0.31) | |
| Return On Capital Employed | (0.34) | (0.36) | |
| Return On Assets | (0.29) | (0.31) | |
| Return On Equity | (0.62) | (0.65) |
Determining Geron's profitability involves analyzing its financial statements and using various financial metrics to determine if Geron is a good buy. For example, gross profit margin measures Geron's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Geron's profitability and make more informed investment decisions.
Evaluate Geron's management efficiency
Geron has return on total asset (ROA) of (0.2198) % which means that it has lost $0.2198 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6609) %, meaning that it created substantial loss on money invested by shareholders. Geron's management efficiency ratios could be used to measure how well Geron manages its routine affairs as well as how well it operates its assets and liabilities. As of the 19th of March 2025, Return On Tangible Assets is likely to drop to -0.31. In addition to that, Return On Capital Employed is likely to drop to -0.36. At this time, Geron's Fixed Asset Turnover is very stable compared to the past year. As of the 19th of March 2025, Asset Turnover is likely to grow to 0.14, while Non Current Assets Total are likely to drop about 4 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.43 | 0.41 | |
| Tangible Book Value Per Share | 0.43 | 0.41 | |
| Enterprise Value Over EBITDA | (14.28) | (13.57) | |
| Price Book Value Ratio | 8.16 | 8.57 | |
| Enterprise Value Multiple | (14.28) | (13.57) | |
| Price Fair Value | 8.16 | 8.57 | |
| Enterprise Value | 2.2 B | 2.3 B |
The strategic initiatives led by Geron's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Beta 0.532 |
Basic technical analysis of Geron Stock
As of the 19th of March, Geron retains the Risk Adjusted Performance of (0.18), standard deviation of 5.16, and Market Risk Adjusted Performance of (1.46). Geron technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Geron's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Geron insiders, such as employees or executives, is commonly permitted as long as it does not rely on Geron's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Geron insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Geron's Outstanding Corporate Bonds
Geron issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Geron uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Geron bonds can be classified according to their maturity, which is the date when Geron has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Understand Geron's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Geron's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.18) | |||
| Market Risk Adjusted Performance | (1.46) | |||
| Mean Deviation | 2.99 | |||
| Coefficient Of Variation | (471.35) | |||
| Standard Deviation | 5.16 | |||
| Variance | 26.6 | |||
| Information Ratio | (0.20) | |||
| Jensen Alpha | (1.04) | |||
| Total Risk Alpha | (0.57) | |||
| Treynor Ratio | (1.47) | |||
| Maximum Drawdown | 36.19 | |||
| Value At Risk | (7.00) | |||
| Potential Upside | 4.12 | |||
| Skewness | (3.19) | |||
| Kurtosis | 19.75 |
| Risk Adjusted Performance | (0.18) | |||
| Market Risk Adjusted Performance | (1.46) | |||
| Mean Deviation | 2.99 | |||
| Coefficient Of Variation | (471.35) | |||
| Standard Deviation | 5.16 | |||
| Variance | 26.6 | |||
| Information Ratio | (0.20) | |||
| Jensen Alpha | (1.04) | |||
| Total Risk Alpha | (0.57) | |||
| Treynor Ratio | (1.47) | |||
| Maximum Drawdown | 36.19 | |||
| Value At Risk | (7.00) | |||
| Potential Upside | 4.12 | |||
| Skewness | (3.19) | |||
| Kurtosis | 19.75 |
Consider Geron's intraday indicators
Geron intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Geron stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 474182.0 | |||
| Daily Balance Of Power | (0.11) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 1.72 | |||
| Day Typical Price | 1.72 | |||
| Price Action Indicator | 0.01 | |||
| Period Momentum Indicator | (0.01) |
Geron Stock media impact
Far too much social signal, news, headlines, and media speculation about Geron that are available to investors today. That information is available publicly through Geron media outlets and privately through word of mouth or via Geron internal channels. However, regardless of the origin, that massive amount of Geron data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Geron news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Geron relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Geron's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Geron alpha.
Geron Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Geron can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Geron Historical Investor Sentiment
Investor biases related to Geron's public news can be used to forecast risks associated with an investment in Geron. The trend in average sentiment can be used to explain how an investor holding Geron can time the market purely based on public headlines and social activities around Geron. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Geron's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Geron and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Geron news discussions. The higher the estimate score, the more favorable the investor's outlook on Geron.
Geron Corporate Management
| Andrew Grethlein | Executive VP of Devel. and Technical Operations | Profile | |
| Faye MD | Executive Officer | Profile | |
| Stephen JD | Chief VP | Profile | |
| Aron Feingold | Vice Communications | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Geron. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.27) | Revenue Per Share | Quarterly Revenue Growth 2.1 K | Return On Assets | Return On Equity |
The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Geron's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.